-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

613. Acute Myeloid Leukemia: Clinical Studies: Poster II

Program: Oral and Poster Abstracts
Type: Poster
Hematology Disease Topics & Pathways:
Adult, ALL, AML, Biological, Leukemia, survivorship, Diseases, drug-drug interaction, Non-Biological, Combinations, Elderly, Therapies, Adverse Events, chemotherapy, MDS, Pediatric, Biological Processes, Immune Disorders, Technology and Procedures, cytogenetics, epigenetics, immunotherapy, Infectious Diseases, Lymphoid Malignancies, Neutropenia, Study Population, Clinically relevant, genetic profiling, genomics, Myeloid Malignancies, Quality Improvement , flow cytometry, molecular testing, NGS, metabolomics, WGS, pathways
Sunday, December 6, 2020: 7:00 AM-3:30 PM

Marina Konopleva, MD, PhD1, Michael Thirman, MD2, Keith W. Pratz, MD3, Anthony G. Letai, MD, PhD4, Christian Recher, MD, PhD5, Vinod A. Pullarkat, MD6, Hagop M. Kantarjian, MD7, Monique Dail, PhD8*, Yinghui Duan, PhD9*, Brenda J. Chyla9, Jalaja Potluri, MD9, Catherine Miller, PharmD9*, Courtney D. Dinardo, MD, MSc7 and Andrew H. Wei, MBBS, PhD10

1University of Texas, MD Anderson Cancer Center, Houston, TX
2Department of Medicine, Section of Hematology-Oncology, University of Chicago, Chicago, IL
3Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA
4Department of Medical Oncology, Dana-Farber Cancer Institute & HMS, Boston, MA
5Université de Toulouse III, Toulouse, France
6Department of Hematology and Hematopoietic Cell Transplantation and Gehr Family Center for Leukemia Research, City of Hope Comprehensive Cancer Center, Duarte, CA
7Department of Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston, TX
8Genentech Inc., South San Francisco, CA
9AbbVie Inc., North Chicago, IL
10The Alfred Hospital and Monash University, Melbourne, VIC, Australia

Sabine Kayser, MD1,2, Jan Moritz Middeke, MD3*, Michael Kramer4*, Katja Sockel, MD3*, Sebastian Stasik, PhD4*, Regina Herbst, MD5*, Lars R. Fransecky, MD6*, Dominik Wolf, Univ. Prof. Dr.7, Schumacher Martin, MD8*, Alwin Krämer, MD9,10*, Richard Noppeney, MD11*, Juergen Novotny, MD11*, Gesine Bug12*, Katharina S. Götze13, Karsten Spiekermann, MD14, Matthias Stelljes, MD15, Jan-Henrik Mikesch, PD, MD16*, Marion Subklewe, MD17, Antje Schubert3*, Anke Mütherig, MD3*, Tilmann Bochtler, MD18,19*, Marika Mende, MD3*, Friedrich Stoelzel, PD, MD4, Anne Kubasch, MD20*, Malte Von Bonin, MD21*, Mathias Haenel, MD5*, Ulrich Duehrsen, MD22, Johannes Schetelig, MD, MSc4, Christoph Rollig, MD, MSC4*, Claudia D Baldus, MD23*, Gerhard Ehninger, MD24,25, Carsten Müller-Tidow, MD26*, Hubert Serve, MD, PhD27, Martin Bornhäuser, MD28*, Uwe Platzbecker, MD29 and Christian Thiede, MD3

1Department of Hematology, University Hospital of Leipzig, Leipzig, Germany
2German Cancer Research Center (DKFZ), Heidelberg, Germany
3Dept. of Internal Medicine I, University Hospital Carl Gustav Carus Dresden, Dresden, Germany
4Department of Internal Medicine I, University Hospital Carl Gustav Carus, Dresden, Germany
5Department of Internal Medicine III, Klinikum Chemnitz, Chemnitz, Germany
6Hematology and Oncology, University Hospital Schleswig-Holstein, Kiel, Germany
7Department of Internal Medicine V, Medical University of Innsbruck, Innsbruck, Austria
8University Hospital Bonn, Bonn, Germany
9Department of Internal Medicine V, University Hospital Heidelberg, Heidelberg, Germany
10Clinical Cooperation Unit Molecular Hematology/Oncology, German Cancer Research Center (DKFZ) and Department of Internal Medicine V, Heidelberg, Germany
11Department of Hematology, University Hospital of Essen, Essen, Germany
12Department of Medicine II, Hematology and Oncology, University Hospital Frankfurt, Goethe University, Frankfurt, Germany
13Department of Medicine III, Technical University of Munich, Munich, Germany
14Laboratory of Leukemia Diagnostics, Department of Medicine III, University Hospital, LMU Munich, Munich, Germany
15Deptartment of Medicine A, University of Muenster, Muenster, Germany
16University Hospital of Muenster, Muenster, Germany
17Department of Medicine III, University Hospital, LMU Munich, Munich, Germany
18Department of Internal Medicine V, University Hospital of Heidelberg, Heidelberg, Germany
19Clinical Cooperation Unit Molecular Hematology/Oncology, German Cancer Research Center, Heidelberg, Germany
20Medical Clinic and Policlinic 1, Hematology and Cellular Therapy, University Hospital Leipzig, Leipzig, Germany
21Department of Internal Medicine I, University Hospital 'Carl Gustav Carus', TU Dresden, Dresden, Germany
22Department of Hematology, University Hospital Essen, Essen, Germany
23Medical Department II, Hematology and Oncology, University Hospital Schleswig-Holstein, Kiel, Germany
24Cellex Gesellschaft für Zellgewinnung mbH, Dresden, Germany
25Internal Medicine I, University Hospital Carl Gustav Carus, Dresden, Germany
26Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg, Germany
27University Hospital, Department of Medicine II, Hematology/Oncology, Goethe University, Frankfurt, Germany
28Department of Hematology and Oncology, University Hospital Carl Gustav Carus Dresden, Dresden, Germany
29Hematology and Cellular Therapy, University Hospital Leipzig, Leipzig, Germany

William Donnellan, MD1, Tao Xu2*, Esprit Ma3*, Huan Jin3*, Melissa Montez3*, Michelle Choi4*, Grace Ku3*, Raj Anand Rajeswaran2*, Giridharan Ramsingh3* and Evelyn M. Flahavan5*

1Sarah Cannon Research Institute, Nashville, TN
2F. Hoffmann-La Roche Ltd, Basel, Switzerland
3Genentech, Inc., South San Francisco, CA
4AbbVie Inc., North Chicago, IL
5Roche Products Ltd, Welwyn Garden City, United Kingdom

Katharina Waack1,2,3*, Markus Schneider, PhD4*, Christiane Walter, MSc5*, Ursula Creutzig, MD6*, Jan-Henning Klusmann7, Mareike Rasche, MD4*, Heidrun Boztug8*, Katharina Jansen, PhD2,9*, Gabriele Escherich, MD10*, Michael Frühwald, MD11*, Michael Dworzak, MD, PhD8* and Dirk Reinhardt, MD12

1Center for Research Acceleration in Pediatrics, Essen, Germany
2Pediatric Research Network, Essen, Germany
3Pediatric Hematology/Oncology, University Hospital Essen, Essen, DEU
4Department of Pediatric Hematology and Oncology, University Hospital Essen, Essen, Germany
5Department of Pediatrics III, University Children's Hospital Essen, University of Duisburg-Essen, Essen, Germany
6Pediatric Hematology and Oncology, Medical School Hannover, Hannover, Germany
7Pediatric Hematology and Oncology, Martin-Luther-University Halle-Wittenberg, Halle (Saale), Germany
8St. Anna Children's Hospital and Cancer Research Institute, Medical University of Vienna, Vienna, Austria
9Pediatrics III, University Hospital Essen, Essen, Germany
10Department of Pediatric Hematology and Oncology, University Medical Center Hamburg, Hamburg, Germany
117Pediatric and Adolescent Medicine, Swabian Children´s Cancer Center, University Medical Center Augsburg, Augsburg, Germany
12Department of Pediatric Hematology and Oncology, Essen University Hospital, Essen, Germany

Sonja Loges, MD, PhD1,2*, Michael Heuser3, Jörg Chromik, MD4*, Carlos Enrique Vigil, MD5, Peter Paschka, MD6, Francesca Re, MD7*, Nicola Di Renzo, MD8*, Roberto M. Lemoli9, Daniele Giovanni Mattei, MD10, Isabel Ben-Batalla, PhD11*, Monica Hellesoy, PhD12*, Katherine Lorens, MD13*, Joseph Birkett, PhD13*, Stuart McPherson, BSc13*, Jaya Nautiyal, PhD13*, David Micklem, PhD13*, Hani Gabra, MD, PhD, FRCPE, FRCP13*, James B. Lorens, PhD13,14*, Walter Fiedler, MD15, Yesid Alvarado, MD16 and Bjorn T. Gjertsen, MD, PhD17

1University Medical Centre Manheim, Manheim, Germany
2German Cancer Research Centre (DKFZ), Heidelberg, Germany
3Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany
4University Hospital Frankfurth, Frankfurt, Germany
5Vanderbilt Ingram Cancer Centre, Nashville, TN
6University Hospital Ulm, Ulm, Germany
7University of Parma, Parma, Italy
8Hematology and SCT Unit, Vito Fazzi Hospital, Lecce, Italy
9University of Genoa, Genoa, Italy
10Azienda Ospedaliera S. Croce e Carle, Cuneo, Italy
11Medical Clinic and Institute of Tumor Biology, Campus Forschung, University Hospital Hamburg-Eppendorf, Hamburg, Germany
12Haukeland University Hospital, Bergen, Norway
13BerGenBio ASA, Bergen, Norway
14Centre for Cancer Biomarkers, University of Bergen, Bergen, Norway
15University Medical Center, Hamburg-Eppendorf, Hubertus-Wald University Cancer Center, Hamburg, Germany
16Department of Leukemia, MD Anderson Cancer Center, Houston, TX
17Centre for Cancer Biomarkers, Department of Clinical Science, University of Bergen, Bergen, Norway

Amer M. Zeidan, MBBS, MHS1, Prajwal C Boddu, MBBS2, Brent L Wood, MD, PhD3, Daniel Zelterman4*, Richard F. Little, MD, MPH5, S. Percy Ivy, MD6*, Anne Caldwell7*, Beatriz Sanchez-Espiridion8*, Gheath Alatrash8, Elad Sharon, MD, MPH9* and Jerald P. Radich, MD10

1Section of Hematology, Department of Internal Medicine, Yale University School of Medicine and Yale Cancer Center, New Haven, CT
2Yale cancer center, Department of Hematology, Yale University School of Medicine, new haven, CT
3Department of Laboratory Medicine,, University of Washington, Seattle, WA
4Yale School of Public Health, New Haven, CT
5National Cancer Institute, Washington, DC
6National Cancer Institute Cancer Therapy Evaluation Program, Rockville, MD
7Yale cancer center, Yale University, new haven, CT
8MD Anderson Cancer Center, Houston, TX
9Division of Cancer Treatment and Diagnosis, National Cancer Institute, Cancer Therapy Evaluation Program, Bethesda, MD
10Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA

Nicholas J. Short, MD1, Shouhao Zhou2*, Chenqi Fu2*, Donald Berry, MD, PhD3*, Roland P Walter, MD PhD4, Sylvie D Freeman5*, Christopher S. Hourigan, MD, DPhil6, Xuelin Huang, PhD3*, Graciela M. Nogueras González, MPH3*, Hyunsoo Hwang3*, Xinyue Qi3*, Hagop M. Kantarjian, MD1 and Farhad Ravandi, MBBS1

1Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
2Department of Public Health Sciences, Penn State College of Medicine, Hershey, PA
3Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX
4Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA
5Institute of Immunology and Immunotherapy, University of Birmingham, Cheltenham, United Kingdom
6Laboratory of Myeloid Malignancies, Hematology Branch, NHLBI, Bethesda, MD

J. Erika Haydu, MD, PhD1*, Yael Flamand2*, Rahul S. Vedula, MD1, Jurjen Versluis3*, Anne Charles, BS1*, Kevin Copson, MA1*, Donna S. Neuberg, ScD2, R. Coleman Lindsley, MD, PhD1 and Marlise R Luskin, MD, MS4

1Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
2Department of Data Sciences, Dana-Farber Cancer Institute, Boston, MA
3Department of Medical Oncology, Dana-Farber Cancer Institute, Jamaica Plain, MA
4Department of Medical Oncology, Dana-Farber Cancer Institute, Boston

Andrew J Klink, PhD, MPH1*, Ronda Copher, PhD2*, Russell L. Knoth2*, Landon Marshall, PharmD, PhD1*, Ying Hou, MD1*, Ajeet Gajra, MD, MBBS1 and Raoul Tibes, MD, PhD3*

1Cardinal Health Specialty Solutions, Dublin, OH
2Bristol Myers Squibb, Princeton, NJ
3Department of Internal Medicine II, University Hospital Würzburg, Würzburg, Germany

Daehun Kwag, M.D.1*, Byung Sik Cho, M.D., Ph.D.2*, Gi June Min, M.D.2,3*, Sung-Soo Park2*, Silvia Park, M.D, Ph.D.4*, Jae-Ho Yoon, M.D, Ph.D.5*, Sung-Eun Lee, M.D, Ph.D.6*, Ki-Seong Eom, M.D., Ph.D.5*, Yoo-Jin Kim, M.D., Ph.D.5, Seok Lee, M.D., Ph.D.5, Chang-Ki Min, M.D, Ph.D.7*, Seok-Goo Cho, M.D., Ph.D.8*, Dong-Wook Kim, MD5, Jong Wook Lee, M.D., Ph.D.9 and Hee-Je Kim, M.D, Ph.D.5

1Catholic Hematology Hospital, Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea, Republic of (South)
2Department of Hematology, Catholic Hematology Hospital and Leukemia Research Institute, Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea, Republic of (South)
3Catholic Blood and Marrow Transplantation Center, Division of Hematology, Department of Internal Medicine, Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea, Republic of (South)
4Department of Hematology, Catholic Hematology Hospital and Leukemia Research Institute, Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea, Seoul, Gangnam-Gu, Korea, Republic of (South)
5Department of Hematology, Catholic Hematology Hospital and Leukemia Research Institute, Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea, Seoul, Korea, Republic of (South)
6Department of Hematology, Catholic Hematology Hospital and Leukemia Research Institute, Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Houston, TX
7Division of Hematology, Department of Internal Medicine, Seoul St. Mary’s Hospital, The Catholic University of Korea, Seoul, Korea, Republic of (South)
8Department of Haematology, Catholic Blood and Marrow Transplantation Center, Seoul St. Mary’s Hospital, The Catholic University of Korea, Seoul, Korea, Republic of (South)
9Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea, Republic of (South)

Takeshi Kondo, MD, PhD1, David Sanford, MD2, Ciprian Tomuleasa, MD3*, Hui-Hua Hsiao, MD4*, Leonardo José Enciso Olivera, MD5*, Anoop Kumar Enjeti, MBBS, FRCPA, FRACP, PhD, MD, MRCP6, Alberto Giménez Conca, MD7*, Teresa Bernal del Castillo, MD, PhD8*, Larisa Girshova, MD, PhD9*, Maria Paola Martelli, MD, PhD10, Birol Güvenç, MD11*, Alexander Tayco Delgado, MD12*, Yinghui Duan, PhD13*, Maria Belen Garbayo Guijarro, MBBS14*, Cynthia Llamas, MS13* and Je-Hwan Lee, MD, PhD15

1Blood Disorders Center, Aiiku Hospital, Sapporo, Japan
2Leukemia/Bone Marrow Transplant Program of British Columbia, University of British Columbia, Vancouver, BC, Canada
3Department of Hematology, Ion Chiricuta Clinical Cancer Center, Cluj-Napoca, Romania
4Division of Hematology‐Oncology, Department of Internal Medicine, Kaohsiung Medical University Hospital and Kaohsiung Medical University, Kaohsiung, Taiwan
5Instituto Nacional de Cancerologia, Bogatá, Colombia
6Calvary Mater Newcastle Hospital, Sydney, Australia
7Section of Hematology, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina
8Hospital Universitario Central Asturias, ISPA, IUOPA, Oviedo, Spain
9Federal State Budgetary Institution “Almazov National Medical Research Centre” of the Ministry of Health of the Russian Federation, St. Petersburg, Russian Federation
10Department of Medicine – Section of Hematology and Clinical Immunology, Perugia University, "Santa Maria della Misericordia" Hospital, Perugia, Italy
11Department of Hematology, Faculty of Medicine, Çukurova University, Adana, Turkey
12AbbVie Inc., Singapore, Singapore
13AbbVie Inc., North Chicago, IL
14AbbVie Inc., Madrid, Spain
15Department of Hematology, University of Ulsan College of Medicine and Asan Medical Center, Seoul, Korea, Republic of (South)

Daniel Rivera, MD1*, Hagop M. Kantarjian, MD1, Gautam Borthakur, MD1, Marina Konopleva, MD, PhD2, Rashmi Kanagal-Shamanna, MD3, Naveen Pemmaraju, MD4, Naval Daver, MD1, Courtney D. DiNardo, MD, MSc5, Koichi Takahashi, MD, PhD1, Elias Jabbour, MD1, Guillermo Montalban-Bravo, MD1*, Musa Yilmaz, MD1, Sherry A. Pierce, BSN, BA1*, Michael Andreeff, MD, PhD6, Kapil N. Bhalla, MD7, Guillermo Garcia-Manero, MD1, Farhad Ravandi, MBBS1 and Tapan M. Kadia, MD1

1Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
2Department of Leukemia, University of Texas, MD Anderson Cancer Center, Houston, TX
3Department of Hematopathology, Division of Pathology/Lab Medicine, University of Texas MD Anderson Cancer Center, Houston, TX
4University of Texas MD Anderson Cancer Center, Department of Leukemia, Houston, TX
5Department of Leukemia, UT MD Anderson Cancer Center, Houston, TX
6Section of Molecular Hematology and Therapy, Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
7Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX

Olga Salamero, MD1*, Tim C.P Somervaille, PhD, FRCP, FRCPath2, Antonieta Molero, MD3*, Evelyn Acuña, MD4*, Ana Perez, MD5*, Isabel Cano, MD4*, Rebeca Rodríguez-Veiga, MD4*, Sonia Gutierrez6*, Roger Bullock, MD6*, Carlos Buesa, PhD6*, Francesc Bosch, MD, PhD3 and Pau Montesinos, MD, PhD7*

1Department of Hematology, University Hospital Vall d’Hebron, Experimental Hematology, Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Barcelona Hospital Campus, Passeig Vall d'Hebron 119-129, 08035, Barcelona, Spain
2The Christie Hospital, Cancer Research UK Manchester Institute, Manchester, United Kingdom
31. Servei d’Hematologia, Vall d’Hebron Hospital Universitari, Experimental Hematology, Vall d’Hebron Institute of Oncology (VHIO), Departament de Medicina, Universitat Autònoma de Barcelona,, Barcelona, Spain
4Hospital Universitario y Politécnico La Fe, Valencia, Spain
5Department of Hematology, University Hospital Vall d’Hebron, Barcelona, Spain
6Oryzon Genomics SA, Cornella de Llobregat, Spain
7Hospital Universitari i Politècnic La Fe, Valencia, Spain

Farhad Ravandi, MBBS1, Christopher Pocock, MBBS2, Dominik Selleslag, MD3, Pau Montesinos, MD, PhD4*, Hamid Sayar, MD, MSc5, Maurizio Musso, MD6*, Angela Figuera Alvarez7*, Hana Safah, MD8, William Tse, MD, FACP9*, Sang Kyun Sohn, MD, PhD10*, Devendra Hiwase, MBBS, MD, FRACP, FRCPA, PhD11, Timothy Chevassut12*, Francesca Pierdomenico13*, Ignazia La Torre14*, Barry Skikne, MD15,16*, Keshava Kumar, PhD16*, Qian Dong, DrPH16*, C.L. Beach, PharmD16* and Hervé Dombret, MD17,18

1Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
2Kent & Canterbury Hospital, Canterbury, United Kingdom
3AZ Sint-Jan Brugge-Oostende AV, Bruges, Belgium
4Hospital Universitari i Politecnic la Fe, Valencia, and CIBERONC Instituto de Salud Carlos III, Madrid, Spain
5Indiana University Cancer Center, Indianapolis, IN
6La Maddalena - Casa di Cura, Palermo, Italy
7Hospital Universitario de La Princesa, Madrid, Spain
8Section of Hematology and Medical Oncology, Department of Medicine, Tulane University, New Orleans, LA
9University of Louisville School of Medicine, Louisville, KY
10Kyungpook National University Hospital, Daegu, Korea, Republic of (South)
11Royal Adelaide Hospital, Adelaide, Australia
12Haematology Department, Brighton & Sussex University Hospitals NHS Trust, Brighton, United Kingdom
13Portuguese Institute of Oncology Lisbon, Lisbon, Portugal
14Celgene, a Bristol-Myers Squibb Company, Boudry, Switzerland
15Kansas University Medical Center, Kansas City, KS
16Bristol Myers Squibb, Princeton, NJ
17Hôpital Saint-Louis, Assistance Publique – Hôpitaux de Paris (AP-HP), Paris, France
18Institut de Recherche Saint Louis, Université de Paris, Paris, France

Giulia Petrone, MD, MBBS1, Charles Gaulin, MBBS2*, Andriy Derkach, PhD3*, Sean M. Devlin, PhD3*, Ashwin Kishtagari, MBBS4, Rekha Parameswaran, MD5* and Eytan M. Stein, MD6

1Internal Medicine, Icahn School of Medicine/Mount Sinai Morningside and West Hospital, New York City, NY
2Division of Hematology and Medical Oncology, Mayo Clinic, Phoenix, AZ
3Department of Biostatistics and Epidemiology, Memorial Sloan Kettering Cancer Center, New York, NY
4Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic Foundation, Cleveland, OH
5Department of Medicine, Hematology Service, Memorial Sloan Kettering Cancer Center, New York City, NY
6Department of Medicine, Leukemia Service, Memorial Sloan Kettering Cancer Center, New York, NY

Mareike Rasche, MD1*, Emma Steidel1*, Martin Zimmermann2*, Jean-Pierre Bourquin, MD, PhD3, Heidrun Boztug4*, Iveta Janotová5*, Edward A. Kolb, MD6, Thomas Lehrnbecher7*, Nils Von Neuhoff, PhD1*, Naghmeh Niktoreh1*, Nora Muehlegger4*, Lucie Sramkova, MD5*, Jan Stary, MD, PhD5*, Christiane Walter, MSc1*, Ursula Creutzig, MD, PhD2*, Michael Dworzak, MD, PhD4* and Dirk Reinhardt, MD1

1Department of Pediatric Hematology and Oncology, University Hospital Essen, Essen, Germany
2Department of Paediatric Haematology and Oncology, Hannover Medical School, Hannover, Germany
3Division of Pediatric Oncology, and Children Research Center, University Children´s Hospital, Zurich, Switzerland
4St. Anna Children's Hospital and Cancer Research Institute, Medical University of Vienna, Vienna, Austria
5Department of Pediatric Hematology and Oncology, Second Faculty of Medicine, Charles University and University Hospital Motol, Prague, Czech Republic
6Nemours/Alfred I. Dupont Hospital for Children, Wilmington, DE
7Division for Pediatric Hematology and Oncology, University of Frankfurt, Frankfurt, DEU

Anand Ashwin Patel, MD1, Alexandra E Rojek, MD2*, Howard Weiner1*, Michael W. Drazer, MD1*, Lucy A. Godley, MD, PhD1, Michelle M. Le Beau, PhD3 and Richard A. Larson, MD3,4

1Department of Medicine, Section of Hematology-Oncology, University of Chicago, Chicago, IL
2Department of Medicine, University of Chicago, Chicago, IL
3University of Chicago Comprehensive Cancer Center, Chicago, IL
4Department of Medicine, Section of Hematology/Oncology, University of Chicago, Chicago, IL

Uttam K. Rao, MD, MBA1, Heidi Chen, PhD2*, Katie S. Gatwood, PharmD3*, Michael T. Byrne, DO1, Salyka M. Sengsayadeth, MD1*, Stacey A. Goodman, MD1*, Bhagirathbhai Dholaria, MBBS4, Adetola A. Kassim, MD, MS1, Bipin N. Savani, MD1, Wichai Chinratanalab, MD1, Kathryn A. Culos, PharmD3*, Michael R. Savona, MD1 and Brian G. Engelhardt, MD1

1Department of Medicine, Division of Hematology and Oncology, Vanderbilt University Medical Center, Nashville, TN
2Department of Biostatistics, Vanderbilt University Medical Center, Nashville, TN
3Department of Pharmacy, Vanderbilt University Medical Center, Nashville, TN
4Department of Medicine, Division of Hematology and Oncology, Vanderbilt University Medical center, Nashville, TN

Veronica A Guerra, MD1, Yasmin Alwash, MD2, Yan Yuanqing, PhD3*, Jorge M. Ramos Perez, MD4*, Guillaume Richard-Carpentier, MD4, Ahmad S Alotaibi4*, Hycienth O Ahaneku, MD, MPH, PhD4, Bachar Samra, MD4*, Arrvind Raghunath, MD4*, Guillermo Montalban-Bravo, MD4*, Naveen Pemmaraju, MD4, Courtney D. DiNardo, MD, MSc4, Naval Daver, MD4, Gautam Borthakur, MD5, Jorge E. Cortes, MD4,6, Farhad Ravandi, MBBS4, Hagop M. Kantarjian, MD4, Guillermo Garcia-Manero, MD4 and Tapan M. Kadia, MD4

1Department of Leukemia, The University of Texas MD Anderson Cancer Center, Miami, FL
2Department of Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston, TX
3University of Texas Health Science Center, Department of Neurosurgery, Houston
4Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
5Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX
6Georgia Cancer Center Augusta University, Augusta, GA

Andrea Massimiliano Tomirotti, PhD1*, Daniela Bellarosa2*, Scott R. Solomon, MD3, Aziz Nazha, MD4, Stephen A Strickland, MD, MSCI5, Roland P Walter, MD PhD6, Farhad Ravandi, MBBS7, Krzysztof Brzózka, PhD8, Milena Mazan, PhD9*, Simone Baldini, MD10*, Massimiliano Salerno11*, Monica Binaschi, PhD12*, Dirk Laurent, MD13* and Andrea Pellacani, PhD, MD14*

1Experimental and Translational Oncology Department, Menarini Ricerche S.p.A., Pomezia, Italy
2Experimental and Translational Oncology Department, Menarini Ricerche S.p.A., Pomezia (Rome), Italy
3Leukemia Program, Northside Hospital Cancer Center Institute, Atlanta, GA
4Cleveland Clinic, Cleveland
5Vanderbilt University Medical Center, Nashville, TN
6Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA
7MD Anderson Cancer Center, Houston, TX
8Ryvu Therapeutics S.A., Cracow, Poland
9Ryvu Therapeutics, Cracow, Poland
10Menarini Ricerche S.p.A., Firenze, Italy
11Experimental and Translational Oncology Department, Menarini Ricerche S.p.A., Pomezia (RM), Italy
12Preclinical and Translational Sciences, Menarini Ricerche S.p.A., Pomezia (RM), Italy
13Menarini Ricerche/BERLIN-CHEMIE AG, Berlin, Germany
14Menarini Ricerche S.p.A., Firenze, Florence, Italy

Kensuke Matsuda, MD1, Taisuke Jo2*, Kazuhiro Toyama, MD, PhD3*, Kumi Nakazaki3*, Hideo Yasunaga, MD, PhD4* and Mineo Kurokawa, MD, PhD3

1University, Bunkyo-Ku, TKY, Japan
2Department of Health Services Research, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan
3Department of Hematology and Oncology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan
4Department of Clinical Epidemiology and Health Economics, School of Public Health, The University of Tokyo, Tokyo, Japan

Caitlin R. Rausch, PharmD1*, Adam DiPippo, PharmD1*, Prithviraj Bose, MD2 and Dimitrios P. Kontoyiannis, MD3*

1Department of Pharmacy, The University of Texas MD Anderson Cancer Center, Houston, TX
2Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
3Department of Infectious Diseases, The University of Texas MD Anderson Cancer Center, Houston, TX

Claire Andrews1*, Eshetu G Atenafu, M.Sc., P.Stat2*, Georgina S. Daher-Reyes, MD1*, Taylor Young1*, Steven M Chan, MD, PhD1, Vikas Gupta, MD, FRCP, FRCPath1, Dawn Maze, MD, FRCPC, MSc3, Caroline J McNamara, MBBS1, Mark D. Minden1, Tracy Murphy, MD, FRCP, FRCPath1, Aaron D Schimmer, MD, PhD1, Andre C. Schuh1, Karen W.L. Yee, MD1 and Hassan Sibai, MBBS1*

1Leukemia Program, Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada
2Department of Biostatistics, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada
3Leukemia Program, Division of Medical Oncology and Hematology, The Ottawa Hospital, Toronto, ON, Canada

Jacopo Nanni, MD1*, Ernesta Audisio, MD2*, Maria Benedetta Giannini, MD3*, Barbara MD Scappini4*, Benedetta Cambò, MD5*, Francesco Albano6*, Maria Paola Martelli, MD, PhD7, Alessandro Cignetti, MD, PhD8, Gian Matteo Rigolin9*, Nicola Fracchiolla, MD10*, Monica Bocchia11*, Claudio Romani12*, Elisabetta Todisco, MD PhD13*, Monia Lunghi, MD, PhD14*, Anna Maria Mianulli, MD15*, Daniela Cilloni, MD, PhD16*, Elisabetta Petracci17*, Irene Valli17*, Chiara Zingaretti17*, Claudio Cerchione, MD, PhD3, Delia Cangini3*, the FLAM collaborative Group17*, Cristina Papayannidis, MD, PhD18 and Giovanni Martinelli, MD19

1Institute of Hematology “L. and A. Seràgnoli”, Department of Experimental, Diagnostic and Specialty Medicine, University of Bologna, Bologna, Italy
2SC Ematologia 2, Dipartmento di Ematologia e Oncologia, AOU Città della Salute e della Scienza, Torino, Italy
3Hematology Unit, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola (FC), Italy
4Azienda Ospedaliero-Universitaria Careggi, AOU Careggi, SODc Ematologia, Florence, ITA
5Department of Medicine and Surgery, Hematology and BMT Unit, University of Parma, Parma, Italy
6Hematology and Stem cell Transplantation Unit - Department of Emergency and Organ Transplantation (D.E.T.O.) - University of Bari, Bari, Italy
7Department of Medicine – Section of Hematology and Clinical Immunology, Perugia University, "Santa Maria della Misericordia" Hospital, Perugia, Italy
8Divisione Universitaria di Ematologia e Terapie Cellulari, A.O. Ordine Mauriziano, Turin, Italy
9Hematology, St. Anna University Hospital, Cona, Ferrara, Italy
10UOC Oncoematologia, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico Di, Milan, ITA
11Hematology, University of Siena, Siena, Italy
12Ematologia e CTMO, Ospedale Businco, AOB, Cagliari, Cagliari, CA, ITA
13European Institute of Oncology, Milano, Italy
14Division of Hematology, Department of Translational Medicine, University of Eastern Piedmont, Novara, Italy
15Ospedale Infermi, AUSL Romagna, UOC Ematologia, Rimini, ITA
16Department of Clinical and Biological Sciences, University of Turin, Turin, Italy
17IRST IRCCS, Istituto Scientifico per lo Studio e la Cura dei Tumori, Meldola, Italy
18Institute of Hematology "L. e A. Seràgnoli", Department of Oncology and Hematology, Azienda Ospedaliero-Universitaria S. Orsola-Malpighi, Bologna, Italy
19Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori IRST IRCCS, Meldola, Italy

Daniel R Reed, MD1, John Wang2*, Ramey Elsarrag, MS/MD3*, Krista M. Isaac, MD4* and Michael K Keng, MD4

1Section on Hematology/Oncology, Wake Forest Baptist Health Comprehensive Cancer Center, Clemmons, NC
2University of Virginia, Charlottesville, VA
3University of Virginia Health System, Charlottesville, VA
4Division of Hematology/Oncology, University of Virginia Health System, Charlottesville, VA

Alex Legg1*, Tracey Ellison2*, Matthew O'Connell2* and Mark Evans2*

1Jazz Pharmaceuticals, Oxford, United Kingdom
2Harvey Walsh, Runcorn, United Kingdom

Xia Bi, MD, MS1, Zachary French, MD2*, Margaret Kasner, MD, MSc3, Gina Keiffer, MD3, Lindsay Wilde, MD3 and Neil Palmisiano, MD, MS3

1Department of Medical Oncology, Thomas Jefferson University, Bear, DE
2Department of Medicine, Thomas Jefferson University, Philadelphia, PA
3Division of Hematologic Malignancies and Hematopoietic Stem Cell Transplantation, Department of Medical Oncology, Thomas Jefferson University, Philadelphia, PA

Zaid Abdel Rahman, MD1, Yesesri Cherukuri2*, Michael G. Heckman3*, Laura E. Finn, MD4, Liuyan Jiang, MD5, Lisa Z. Sproat, MD6, James R. Cerhan, MD, PhD7, Yan Asmann, PhD2 and James M. Foran, MD1

1Division of Hematology and Medical Oncology, Mayo Clinic, Jacksonville, FL
2Division of Biomedical Statistics and Informatics, Mayo Clinic, Jacksonville, FL
3Biostatistics & Health Sciences Research, Mayo Clinic, Jacksonville, FL
4Ochsner Medical Center, New Orleans, LA
5Department of Laboratory Medicine and Pathology, Mayo Clinic, Jacksonville, FL
6Division of Hematology and Medical Oncology, Mayo Clinic, Phoenix, AZ
7Division of Hematology, Mayo Clinic, Rochester, MN

*signifies non-member of ASH